ニッカトー, 昭栄薬品, 日本インシュ and 和田興産 reported strong first-half results after the close on the 18th, with substantial upward revisions to their earnings forecasts and higher dividends. Full-year forecasts are expected to be either maintained or revised upward, depending on the company.
ニッカトー raised its ordinary profit forecast for the first half of the fiscal year ending March 2027 from the previous forecast of ¥630 million to ¥860 million, substantially increasing its expected growth rate. Orders grew on strong demand in the electronic components industry, driving revenue above plan. The full-year profit forecast was also raised from the previous forecast of ¥1.15 billion to ¥1.29 billion. Alongside the substantial increase in first-half profit, the company raised its dividend by ¥4 and expects to pay an annual dividend of ¥27.
昭栄薬品 raised its first-half ordinary profit forecast from ¥300 million to ¥520 million and expects profit to increase 44.8%, marking its highest first-half profit in four fiscal years. Inventory buildup amid uncertainty over the situation in the Middle East contributed to the result, while the pass-through of higher selling prices also boosted profit. The full-year forecast was left unchanged.
日本インシュ raised its first-half ordinary profit forecast from the previous forecast of ¥270 million to ¥370 million, reflecting new orders and additional orders for ongoing construction projects. The full-year profit forecast was left unchanged.
和田興産 raised its first-half ordinary profit forecast from the previous forecast of ¥900 million to ¥1.35 billion. The revision was driven by the earlier-than-planned recognition of sales in the real estate sales segment and improved profitability in condominium sales. The first-half dividend was increased from ¥25 to ¥32, bringing the annual dividend to ¥67. The full-year profit forecast was left unchanged.